Vave Health Addresses the Prohibitive Cost of Medical Imaging

October 27, 2020

Vave Health is addressing the prohibitive cost of medical imaging by offering clinicians and medical students a portable device to provide enhanced care no matter one’s physical location or environmental barriers. The company are makers of innovative handheld ultrasound technology. With various subscription plans available, Vave Health provides a new model for imaging technology that is making ultrasounds more accessible to providers, patients, and today’s rising medical professionals.

Vave Health is backed by a team of industry leaders and experienced engineers and is rapidly growing, and is well-positioned to revolutionize the physician-patient experience through innovative, industry-transforming technologies. With the recent appointment of Dr. Renee Dversdal as chief medical officer, the company is also actively recruiting for a satellite office in the Seattle market and sets its sights on 2021 for continued growth. Vave Health is also expanding its Global Health Program in the coming months to provide improved access to ultrasound imaging throughout developing countries in Africa and other remote parts of the world.

Vave Health’s unique subscription model is able to provide users with flexible options to fit their needs and offers an industry-first complimentary upgrade to the latest probe every 24 months. Subscription includes the Vave wireless probe with various scanning modes, a battery, charger, and standard warranty. All Vave members can also access on-demand education and advice from Vave’s clinician partners.

“With our ultrasound platform-as-a-service model, we’re able to offer users uncompromised quality at an accessible price point. We can now provide partners with a platform that evolves with them,” said Amin Nikoozadeh, CEO and founder, Vave Health. “Clinicians, health systems, and medical students can now equip themselves to provide enhanced medical care no matter where they are through a unique and all-inclusive service, which provides a wireless probe, access to mentors and free upgrades every 24 months.”

Vave Health also recently announced a partnership with Touro University Nevada, addressing the need to provide the next generation of physicians easy access to medical imaging and training. The partnership supplies students at Touro, which is Nevada’s largest school of medicine and the state’s only school of osteopathic medicine, with a personal wireless Vave Health ultrasound and an ongoing Vave EduPlus Membership.

The Vave ultrasound device was designed with the input of leading health care professionals to create a disruptive technology that is truly affordable and accessible. The cordless device allows users to practice untethered scanning and view clinical images on a smartphone via Vave’s mobile application. Vave Health products and services are commercially available to health systems, physicians, and medical schools and students. Vave’s products and services are available for use by a licensed healthcare professional.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy